000			01508 a2200457 4500
005			20250513101926.0
264		0	_c19961022
008			199610s 0 0 eng d
022			_a0035-8819
040			_aNLM _beng _cNLM
100	1		_aThomas, G A
245	0	0	_aIs transdermal nicotine associated with cardiovascular risk? _h[electronic resource]
260			_bJournal of the Royal College of Physicians of London _c
300			_a392-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Cutaneous
650	0	4	_aAdult
650	0	4	_aCardiovascular System _xdrug effects
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFibrinogen _xanalysis
650	0	4	_aHemoglobins _xanalysis
650	0	4	_aHemostasis _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukocyte Count
650	0	4	_aLipids _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNicotine _xadministration & dosage
650	0	4	_aP-Selectin _xanalysis
650	0	4	_aPlatelet Activation _xdrug effects
650	0	4	_aPlatelet Count
650	0	4	_avon Willebrand Factor _xanalysis
700	1		_aDavies, S V
700	1		_aRhodes, J
700	1		_aRussell, M A
700	1		_aFeyerabend, C
700	1		_aSäwe, U
773	0		_tJournal of the Royal College of Physicians of London _gvol. 29 _gno. 5 _gp. 392-6
999			_c8841855 _d8841855